Plus Power, which recently relocated its HQ to Houston, has moved into a larger office space. Image via cushmanwakefield.com

A Northern California-born energy storage startup has established its headquarters in The Woodlands.

Plus Power, which develops battery systems designed to store backup power for electric grids, recently signed a lease for nearly 7,000 square feet at Three Hughes Landing in The Woodlands. The company previously was based in coworking space at the Rayford Office Park in Spring.

The company, founded in 2018, shifted its headquarters from San Francisco to the Houston area last year.

“We chose The Woodlands for its beauty, and walkable access to great nearby hotels, restaurants, and healthy groceries,” says Brandon Keefe, CEO of Plus Power. “A Houston base reflects our deep focus on the Texas market, as we are investing nearly $1 billion in several projects here that will be online by the first quarter of 2024, with more in [the works] behind that.”

About 40 employees work from Plus Power’s new office in The Woodlands. Across North America, the company employs about 130 people, including several in Austin. As of July 10, the startup listed nine job openings.

Plus Power develops, owns, and operates utility-scale systems that store energy in huge lithium-ion batteries during low-demand periods. In times of peak demand, power providers can tap into this stored energy.

“Standalone energy storage is rapidly transforming the U.S. energy markets, because it is cheaper than new natural gas plants, faster to build than fossil peakers or transmission, and able to perform diverse energy services,” the company explains in its job postings.

Peakers are backup power plants that run on fossil fuels.

One of Plus Power’s storage facilities is the 100-megawatt Gambit project, which opened two years ago in Angleton. The nearly eight-acre facility supports power supplies for the Electric Reliability Council of Texas (ERCOT), which runs the power grid for 90 percent of Texas.

The company says the Angleton facility has fed backup energy to ERCOT during this year’s and last year’s heatwaves, as well as last December’s winter freeze.

The Gambit facility might ring a bell with some folks in the Houston area. In January 2022, Austin-based automaker Tesla unveiled a backup power storage facility in Angleton. Plus Power bought the project from Tesla in June 2022.

Plus Power’s development pipeline contains 10 gigawatts’ worth of energy storage projects in 28 states and Canada. That includes massive projects on tap for Hawaii and Arizona.

Last November, Plus Power announced it had secured $219 million in debt financing for construction of the 185-megawatt Kapolei project on a roughly eight-acre site in Oahu, Hawaii. The facility will be tied to Hawaiian Electric’s power grid. Mizuho Securities USA and KeyBank led the financing.

This April, Plus Power held a groundbreaking ceremony for the Sierra Estrella project in Tolleson, a Phoenix suburb. The 250-megawatt system will serve Salt River Project (SRP), a utility provider in the Phoenix area. The roughly 11-acre Tolleson facility is set to open next year, as is another Plus Power project for SRP — the 90-megawatt Superstition facility in Gilbert, another Phoenix suburb.

As its development pipeline demonstrates, Plus Power is firmly plugged into the fast-growing energy storage market.

According to the Houston-based energy research and consulting firm Wood Mackenzie and the American Clean Power Association, the U.S. energy storage market installed a record-breaking 4.8 gigawatts of capacity in 2022. This year, that number is projected to approach 75 gigawatts.

In a March 2023 news release, John Hensley, the clean power group’s vice president of research and analytics, says the U.S. market “is on a rapid growth curve and is already a key component of building a resilient grid that supports abundant clean energy.”

------

This article originally ran on EnergyCapital.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”